Zacks Investment Research
05 Jan 2026, 18:00 UTC · 45w ago
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know
Verdict
Source says Upgrade to Buy. We score VVOS +1.00 across two claims.
Score confirms the headline.
- Headline says
Upgrade to Buy
Rating stated in the headline
- Expected · VVOS
+1.00strongly bullish
−1 bearish0bullish +1More positive than 99% of ticker scores this week
- Actual

Search tags




